Facebook
Twitter
LinkedIn
ForwardArchived Monthly Oncology Tumor Boards: Use of Checkpoint Inhibitors for Treatment of Metastatic Colorectal Cancer
It is difficult for clinicians to stay current with the evolving treatment options for colorectal cancer, and they can benefit from education about these therapies.
Category
- Colorectal Cancer
Format
- Recorded Webcast
Credits
- AAPA Category 1 CME credit
- ACPE contact hours
- AMA PRA Category 1 Credit™
- ANCC contact hours
- CCM clock hours
- Participation
Monthly Oncology Tumor Boards: Uveal Melanoma: Treatment of Metastatic Disease
The management of metastatic uveal melanoma still presents a major clinical challenge, and it is important for healthcare providers to be aware of the most current recommendations by the NCCN Panel.
Category
Format
- Live Webinar
Credits
- AAPA Category 1 CME credit
- ACPE contact hours
- AMA PRA Category 1 Credit™
- ANCC contact hours
- CCM clock hours
- Participation
Event date April 10, 2023
Monthly Oncology Tumor Boards: Management of Relapsed/Refractory Mantle Cell Lymphoma
Clinicians are challenged to remain up-to-date about the treatment advances that will enable them to make informed decisions to optimize the clinical outcome of patients with relapsed/refractory disease.
Category
- Non-Hodgkin's Lymphoma
Format
- Live Webinar
Credits
- AAPA Category 1 CME credit
- ACPE contact hours
- AMA PRA Category 1 Credit™
- ANCC contact hours
- CCM clock hours
- Participation
Event date April 18, 2023
Monthly Oncology Tumor Boards: Adjuvant Therapy for Patients with Resectable Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
Clinicians need to know the nuances of using adjuvant targeted therapy and immunotherapy to improve outcomes for their patients with resected early-stage and locally advanced NSCLC.
Category
- Lung Cancers
Format
- Live Webinar
Credits
- AAPA Category 1 CME credit
- ACPE contact hours
- AMA PRA Category 1 Credit™
- ANCC contact hours
- CCM clock hours
- Participation
Event date May 16, 2023